IA
ROIV icon

IFP Advisors’s Roivant Sciences ROIV Stock Holding History

IFP Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Sell
39
-23
-37% -$680 ﹤0.01% 4394
2026
Q1 		$1.72K Buy
62
+27
+77% +$694 ﹤0.01% 4012
2025
Q4 		$760 Buy
35
+25
+250% +$493 ﹤0.01% 4159
2025
Q3 		$151 Buy
+10
New +$124 ﹤0.01% 4454
2025
Q2 		– Hold
0
– – – 1834
2025
Q1 		– Hold
0
– – – 3465
2024
Q4 		– Hold
0
– – – 3382
2024
Q3 		– Sell
-45
Closed -$476 – 3425
2024
Q2 		$476 Buy
+45
New +$493 ﹤0.01% 3095

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

IFP Advisors's ROIV Position: Q2 2026 in Review

IFP Advisors reduced its Roivant Sciences (ROIV) stake by 37% in Q2 2026, selling an estimated $680 and leaving 39 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4394.

IFP Advisors first reported a position in ROIV in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.72K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • IFP Advisors held 39 shares of Roivant Sciences worth $1.38K as of Q2 2026.
  • IFP Advisors sold 23 Roivant Sciences shares in Q2 2026, an estimated $680.
  • Roivant Sciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4394 holding.
  • IFP Advisors first reported a position in Roivant Sciences in Q2 2024 and has held it in 5 quarters since.
  • IFP Advisors's Roivant Sciences position peaked at $1.72K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.